Oral Aminolevulinic Acid Hydrochloride clinical trials
A product of Aminolevulinic Acid; its studies count on that page too.
How each study uses Oral Aminolevulinic Acid Hydrochloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Oral Aminolevulinic Acid Hydrochloride studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 3 Dec 1999 · LEVULAN · NDA 020965 (FDA, Drugs@FDA; as Aminolevulinic Acid)
- European Union
- 7 Sept 2007 · Gliolan · EMEA/H/C/000744 (EMA; as Aminolevulinic Acid)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2026 (3)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 13
Universität Münster (3) · NX Development Corp (2) · University Hospital, Lille (2) · Henry Ford Health System (2) · medac GmbH (1) · Princess Al-Johara Al-Ibrahim Cancer Research Center (1) · Hospices Civils de Lyon (1) · University College, London (1)
Often tested with
Tested in the same studies.
Photodynamic Therapy (1)
Related medicines
As reviewed, each with the page that says it.
- A dosage form of Aminolevulinic Acid source
Studies
Open first, then newest update. How each study uses Oral Aminolevulinic Acid Hydrochloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 16
- Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALARecruitingPhase 2Henry Ford Health SystemNCT06948552Written as 5-Aminolevulinic acid Hydrochloride (Gliolan®)How we know
- Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALARecruitingPhase 2Henry Ford Health SystemNCT07828704Written as 5-Aminolevulinic acid Hydrochloride (Gliolan®)How we know
- Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)RecruitingPhase 3NX Development CorpNCT05804370Written as GleolanHow we know
- Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain TumorRecruitingPhase 1/2Universität MünsterNCT05590689Written as GliolanHow we know
- Fluorescence Guided Focal Cortical Dysplasia SurgeryNot yet recruitingPhase 2Hospices Civils de LyonNCT07657975Written as 5-ALA (Gliolan)How we know
- The Use of 5-ALA in Paediatric Patients With High Grade Brain TumoursNot yet recruitingPhase 2University College, LondonNCT06678867Written as 5-ALA (Gliolan)How we know
- PDT Plus Vitamin D3 for Anal DysplasiaWithdrawnPhase 1Abramson Cancer Center at Penn MedicineNCT02698293Written as GliolanHow we know
- Gleolan for Visualization of Newly Diagnosed or Recurrent MeningiomaCompletedPhase 3NX Development CorpNCT04305470Written as GleolanHow we know
- Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)CompletedPhase 1Universität MünsterNCT06665724Written as 5-Aminolevulinic acid Hydrochloride (Gliolan®)How we know
- INtraoperative photoDYnamic Therapy of GliOblastomaCompletedNot applicableUniversity Hospital, LilleNCT03048240Written as GLIOLANHow we know
- Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain TumorsCompletedPhase 2Universität MünsterNCT04738162Written as 5-Aminolevulinic Acid Hydrochloride, OralHow we know
- Dose Finding for Intraoperative Photodynamic Therapy of GlioblastomaCompletedPhase 2University Hospital, LilleNCT04391062Written as GliolanHow we know
- Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant GliomasCompletedPhase 1/2medac GmbHNCT02755142Written as GliolanHow we know
- More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided SurgeryWithdrawnPhase 2Constantinos HadjipanayisNCT01445691Written as 5-ALA (Gliolan)How we know
- A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of UrineCompletedPhase 3Princess Al-Johara Al-Ibrahim Cancer Research CenterNCT02101931Written as Amino levulinic AcidHow we know
- Photodynamic Therapy for Ulcerative ColitisStatus unknownPhase 1University of ZurichNCT01697670Written as Photodynamic therapy with GliolanHow we know